Race Oncology presents Bisantrene Phase 2 AML trial data at American Society of Hematology conference
Race Oncology Ltd (ASX:RAC, OTC:RAONF) has presented its Bisantrene Phase 2 AML trial data at the 65th American Society of Hematology Annual Conference in...